Abstract

CD8+ T cell-mediated cancer clearance is often suppressed by the interaction between inhibitory molecules like PD-1 and PD-L1, an interaction acts like brakes to prevent T cell overreaction under normal conditions but is exploited by tumor cells to escape the immune surveillance. Immune checkpoint inhibitors have revolutionized cancer therapeutics by removing such brakes. Unfortunately, only a minority of cancer patients respond to immunotherapies presumably due to inadequate immunity. Antitumor immunity depends on the activation of the cGAS-STING pathway, as STING-deficient mice fail to stimulate tumor-infiltrating dendritic cells (DCs) to activate CD8+ T cells. STING agonists also enhance natural killer (NK) cells to mediate the clearance of CD8+ T cell-resistant tumors. Therefore STING agonists have been intensively sought after. We previously discovered that manganese (Mn) is indispensable for the host defense against cytosolic dsDNA by activating cGAS-STING. Here we report that Mn is also essential in innate immune sensing of tumors and enhances adaptive immune responses against tumors. Mn-insufficient mice had significantly enhanced tumor growth and metastasis, with greatly reduced tumor-infiltrating CD8+ T cells. Mechanically, Mn2+ promoted DC and macrophage maturation and tumor-specific antigen presentation, augmented CD8+ T cell differentiation, activation and NK cell activation, and increased memory CD8+ T cells. Combining Mn2+ with immune checkpoint inhibition synergistically boosted antitumor efficacies and reduced the anti-PD-1 antibody dosage required in mice. Importantly, a completed phase 1 clinical trial with the combined regimen of Mn2+ and anti-PD-1 antibody showed promising efficacy, exhibiting type I IFN induction, manageable safety and revived responses to immunotherapy in most patients with advanced metastatic solid tumors. We propose that this combination strategy warrants further clinical translation.

Highlights

  • The immune system recognizes and kills tumor cells, in which the innate immunity is mainly responsible for the detection of tumor cells and the activation of adaptive immunity

  • Mn is essential for antitumor immune responses Since we previously found that Mn was critically involved in innate immune sensing of cytosolic double-stranded DNA (dsDNA) to activate the cGAS-STING pathway, which is important for exerting antitumor immune responses, we hypothesized that Mn would play roles in innate immune responses against tumor cells

  • Intravenously inoculated B16F10 cells in Mn-insufficient mice induced much stronger lung metastasis, compared to the control Mn-sufficient mice (Fig. 1k). These results demonstrated Mn is critical in maintaining the host antitumor immune responses and strongly suggested that Mn is important for preventing tumorigenesis under physiological conditions

Read more

Summary

Introduction

The immune system recognizes and kills tumor cells, in which the innate immunity is mainly responsible for the detection of tumor cells and the activation of adaptive immunity. Clearance of tumor cells is often introverted by the interaction between the inhibitory checkpoint molecules like the programmed cell death protein-1 (PD-1)[1,2] and its ligand such as PD-L1,3 an interaction like a brake to prevent T cell overreaction under normal conditions. PD-L1 or CTLA-4 blocking antibodies have revolutionized cancer therapeutics by removing such inhibitory brakes,[4,5] the effectiveness of which depends on the recognition of tumor-specific antigens to generate and activate tumor-specific CD8+ T cells ( known as cytotoxic T cells, CTLs). NK cells have been found to mediate the clearance of CD8+ T cell-resistant tumors.[6] only about 20% of cancer patients respond to immunotherapies presumably due to inadequate immune activation.[5,7,8]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.